# RIFAMPIN
> **ANDA091181** · Abbreviated New Drug Application (Generic) · Sponsor: FRESENIUS KABI USA · Approved 2014-08-21
## Drug
- **FDA Application Number:** ANDA091181
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** RIFAMPIN
- **Generic name:** RIFAMPIN
- **Active ingredients:** RIFAMPIN
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** FRESENIUS KABI USA
- **Manufacturer:** Fresenius Kabi USA, LLC
- **First approval:** 2014-08-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091181)
---
*AI Analytics · CC0 1.0*